Kallikrein inhibitor MDPK67b
Term · Oncology and biomedicine · MLC-T-ONC-014628
A recombinant protein-based inhibitor of numerous types of kallikrein-related peptidases (KLKs), with potential antineoplastic activity. Upon administration, KLK inhibitor MDPK67b targets and inhibits various KLKs, including KLK2, KLK4, KLK5 and KLK14. This inhibits KLK-mediated signaling and inhibits the proliferation of tumor cells in which these KLKs are overexpressed. Deregulation of KLKs is associated with some types of cancers.
| Identifier | MLC-T-ONC-014628 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | KLK inhibitor MDPK67b |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014628",
"term": "Kallikrein inhibitor MDPK67b",
"field": "Oncology and biomedicine",
"definition": "A recombinant protein-based inhibitor of numerous types of kallikrein-related peptidases (KLKs), with potential antineoplastic activity. Upon administration, KLK inhibitor MDPK67b targets and inhibits various KLKs, including KLK2, KLK4, KLK5 and KLK14. This inhibits KLK-mediated signaling and inhibits the proliferation of tumor cells in which these KLKs are overexpressed. Deregulation of KLKs is associated with some types of cancers.",
"synonyms": [
"KLK inhibitor MDPK67b"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/kallikrein-inhibitor-mdpk67b/"
}
Record 9,722 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.